- Home
- FIVN vs TMDX Comparison
FIVN vs TMDX Comparison
Compare FIVN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVN
- TMDX
- Stock Information
- Founded
- FIVN 2001
- TMDX 1998
- Country
- FIVN United States
- TMDX United States
- Employees
- FIVN N/A
- TMDX N/A
- Industry
- FIVN EDP Services
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FIVN Technology
- TMDX Health Care
- Exchange
- FIVN Nasdaq
- TMDX Nasdaq
- Market Cap
- FIVN 2.3B
- TMDX 2.3B
- IPO Year
- FIVN 2014
- TMDX 2019
- Fundamental
- Price
- FIVN $26.52
- TMDX $111.50
- Analyst Decision
- FIVN Buy
- TMDX Buy
- Analyst Count
- FIVN 20
- TMDX 10
- Target Price
- FIVN $44.40
- TMDX $122.89
- AVG Volume (30 Days)
- FIVN 2.0M
- TMDX 1.2M
- Earning Date
- FIVN 05-01-2025
- TMDX 05-08-2025
- Dividend Yield
- FIVN N/A
- TMDX N/A
- EPS Growth
- FIVN N/A
- TMDX N/A
- EPS
- FIVN N/A
- TMDX 1.41
- Revenue
- FIVN $1,074,633,000.00
- TMDX $488,227,000.00
- Revenue This Year
- FIVN $11.81
- TMDX $25.33
- Revenue Next Year
- FIVN $10.56
- TMDX $20.53
- P/E Ratio
- FIVN N/A
- TMDX $79.36
- Revenue Growth
- FIVN 14.44
- TMDX 64.43
- 52 Week Low
- FIVN $21.04
- TMDX $55.00
- 52 Week High
- FIVN $60.76
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- FIVN 55.90
- TMDX 78.52
- Support Level
- FIVN $24.50
- TMDX $92.49
- Resistance Level
- FIVN $28.30
- TMDX $95.71
- Average True Range (ATR)
- FIVN 1.40
- TMDX 4.79
- MACD
- FIVN 0.56
- TMDX 0.81
- Stochastic Oscillator
- FIVN 74.57
- TMDX 71.36
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.